$706 Million is the total value of Vivo Capital, LLC's 34 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MNLO | New | Menlo Therapeutics | $150,742,000 | – | 4,011,236 | +100.0% | 21.35% | – |
| ASND | Buy | Ascendis Pharmaadr | $141,711,000 | +100.2% | 2,166,832 | +22.6% | 20.08% | +32.4% |
| BHVN | Buy | Biohaven Pharmaceutical Holding Company Ltd | $52,796,000 | -1.0% | 2,049,545 | +3.7% | 7.48% | -34.5% |
| FIXX | New | Homology Medicines, Inc. | $21,687,000 | – | 1,159,742 | +100.0% | 3.07% | – |
| ARWR | New | Arrowhead Pharmaceuticals Inc | $13,699,000 | – | 1,900,000 | +100.0% | 1.94% | – |
| CBAY | New | Cymabay Therapeutics Inc | $10,392,000 | – | 800,000 | +100.0% | 1.47% | – |
| GNCA | New | Genocea Biosciences Inc | $8,589,000 | – | 8,180,000 | +100.0% | 1.22% | – |
| BPMX | Buy | BioPharmX Corporation | $3,726,000 | +145.0% | 16,128,515 | +16.9% | 0.53% | +62.0% |
| MDGL | New | Madrigal Pharmaceuticals Inc | $3,179,000 | – | 27,220 | +100.0% | 0.45% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
| CODEXIS INC | 29 | Q3 2023 | 8.0% |
| ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
| KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
| Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
| AMYRIS INC | 23 | Q3 2023 | 8.8% |
| EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
| Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
| Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
| HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-22 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-08 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.